TY - JOUR
T1 - The Role of β-Transducin Repeat-Containing Protein (β-TrCP) in the Regulation of NF-κB in Vascular Smooth Muscle Cells
AU - Wang, Xiaohong
AU - Adhikari, Neeta
AU - Li, Qinglu
AU - Guan, Zhanjun
AU - Hall, Jennifer L.
PY - 2004/1
Y1 - 2004/1
N2 - Objective-Degradation of IκB is an essential step in nuclear factor (NF)-κB activation. However, the determinants regulating this process have not been defined in vascular smooth muscle cells (VSMCs). We hypothesized that the E3-ligase, β-transducin repeat-containing protein 1 (β-TrCP1), was a rate-determining mediator that regulates the ubiquitin-mediated degradation of IκBα (in VSMC). Methods and Results-Upregulation of β-TrCP1 accelerated the rate of IκBα degradation, leading to increased NF-κB activity. In contrast, VSMCs harboring a dominant-negative β-TrCP1 transgene lacking the F-box domain exhibited a reduction in serum-stimulated NF-κB activity but no alteration in response to tumor necrosis factor (TNF). These findings suggest that β-TrCP1 increases the rate of NF-κB activation but is not rate-limiting in response to TNF in VSMCs. Endogenous β-TrCP1 expression was regulated through the conserved Wnt cascade. Upregulation of Wnt1 resulted in β-catenin-mediated activation of Tcf-4, leading to increased β-TrCP1 expression and NF-κB activity. Furthermore, VSMCs harboring a Tcf-4 mutant lacking a β-catenin binding domain exhibited a significant reduction in β-TrCP1 expression along with abolishment of NF-κB activity. Conclusions-We provide the first evidence of crosstalk between the Wnt cascade and NF-κB signaling in VSMCs. This crosstalk is mediated through the E3-ligase, β-TrCP1.
AB - Objective-Degradation of IκB is an essential step in nuclear factor (NF)-κB activation. However, the determinants regulating this process have not been defined in vascular smooth muscle cells (VSMCs). We hypothesized that the E3-ligase, β-transducin repeat-containing protein 1 (β-TrCP1), was a rate-determining mediator that regulates the ubiquitin-mediated degradation of IκBα (in VSMC). Methods and Results-Upregulation of β-TrCP1 accelerated the rate of IκBα degradation, leading to increased NF-κB activity. In contrast, VSMCs harboring a dominant-negative β-TrCP1 transgene lacking the F-box domain exhibited a reduction in serum-stimulated NF-κB activity but no alteration in response to tumor necrosis factor (TNF). These findings suggest that β-TrCP1 increases the rate of NF-κB activation but is not rate-limiting in response to TNF in VSMCs. Endogenous β-TrCP1 expression was regulated through the conserved Wnt cascade. Upregulation of Wnt1 resulted in β-catenin-mediated activation of Tcf-4, leading to increased β-TrCP1 expression and NF-κB activity. Furthermore, VSMCs harboring a Tcf-4 mutant lacking a β-catenin binding domain exhibited a significant reduction in β-TrCP1 expression along with abolishment of NF-κB activity. Conclusions-We provide the first evidence of crosstalk between the Wnt cascade and NF-κB signaling in VSMCs. This crosstalk is mediated through the E3-ligase, β-TrCP1.
KW - Muscle, vascular, smooth
KW - Nuclear factor-κB
KW - Wnt
KW - β-TrCP1
KW - β-catenin
UR - http://www.scopus.com/inward/record.url?scp=0345861767&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0345861767&partnerID=8YFLogxK
U2 - 10.1161/01.ATV.0000104012.40720.c4
DO - 10.1161/01.ATV.0000104012.40720.c4
M3 - Article
C2 - 14592850
AN - SCOPUS:0345861767
SN - 1079-5642
VL - 24
SP - 85
EP - 90
JO - Arteriosclerosis, thrombosis, and vascular biology
JF - Arteriosclerosis, thrombosis, and vascular biology
IS - 1
ER -